E. J. A. Kroot

1.2k total citations · 1 hit paper
13 papers, 894 citations indexed

About

E. J. A. Kroot is a scholar working on Rheumatology, Hematology and Dermatology. According to data from OpenAlex, E. J. A. Kroot has authored 13 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 4 papers in Hematology and 3 papers in Dermatology. Recurrent topics in E. J. A. Kroot's work include Rheumatoid Arthritis Research and Therapies (6 papers), Systemic Lupus Erythematosus Research (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). E. J. A. Kroot is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Systemic Lupus Erythematosus Research (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). E. J. A. Kroot collaborates with scholars based in Netherlands. E. J. A. Kroot's co-authors include Piet L. C. M. van Riel, Hilde Swinkels, Leo B. A. Van De Putte, Walther J. van Venrooij, F.H.J. van den Hoogen, M. H. van Rijswijk, B.A.W. de Jong, Martin Van 't Hof, M. A. van Leeuwen and J. M. W. Hazes and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Care & Research.

In The Last Decade

E. J. A. Kroot

13 papers receiving 843 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

2000 509 citations E. J. A. Kroot, B.A.W. de Jong et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. J. A. Kroot Netherlands	8	733	207	135	103	90	13	894
Jessica A B van Nies Netherlands	16	710 1.0×	141 0.7×	201 1.5×	104 1.0×	42 0.5×	17	832
Francisco Javier López‐Longo Spain	16	563 0.8×	116 0.6×	125 0.9×	184 1.8×	90 1.0×	52	797
O. Kaye Belgium	11	413 0.6×	72 0.3×	99 0.7×	78 0.8×	136 1.5×	21	641
J. S. Smolen Austria	13	581 0.8×	89 0.4×	220 1.6×	184 1.8×	69 0.8×	24	948
Guro Løvik Goll Norway	13	581 0.8×	184 0.9×	96 0.7×	252 2.4×	45 0.5×	50	831
Tatiana Cobo‐Ibáñez Spain	18	719 1.0×	102 0.5×	212 1.6×	331 3.2×	47 0.5×	34	1.0k
Isabelle Peene Belgium	14	476 0.6×	225 1.1×	57 0.4×	165 1.6×	49 0.5×	31	695
L.E. Burgers Netherlands	16	617 0.8×	123 0.6×	202 1.5×	126 1.2×	31 0.3×	23	724
Anna‐Birgitte Aga Norway	14	662 0.9×	70 0.3×	232 1.7×	117 1.1×	62 0.7×	44	762
Anna Laura Fedele Italy	17	479 0.7×	100 0.5×	179 1.3×	238 2.3×	44 0.5×	48	864

Countries citing papers authored by E. J. A. Kroot

Since Specialization

Citations

This map shows the geographic impact of E. J. A. Kroot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. J. A. Kroot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. J. A. Kroot more than expected).

Fields of papers citing papers by E. J. A. Kroot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. J. A. Kroot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. J. A. Kroot. The network helps show where E. J. A. Kroot may publish in the future.

Co-authorship network of co-authors of E. J. A. Kroot

This figure shows the co-authorship network connecting the top 25 collaborators of E. J. A. Kroot. A scholar is included among the top collaborators of E. J. A. Kroot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. J. A. Kroot. E. J. A. Kroot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Voshaar, Martijn A. H. Oude, Peter M. ten Klooster, Danyta I. Tedjo, et al.. (2024). PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs. RMD Open. 10(2). e004291–e004291. 5 indexed citations

Plasqui, Guy, Annelies Boonen, Piet Geusens, et al.. (2011). Physical activity and body composition in patients with ankylosing spondylitis. Arthritis Care & Research. 64(1). 101–107. 47 indexed citations

Kroot, E. J. A. & Jasper Wouters. (2007). An unusual case of infectious spondylodiscitis. Lara D. Veeken. 46(8). 1296–1296. 3 indexed citations

Kroot, E. J. A., J. M. W. Hazes, Edgar M. Colin, & Radboud J. E. M. Dolhain. (2006). Poncet's disease: reactive arthritis accompanying tuberculosis. Two case reports and a review of the literature. Lara D. Veeken. 46(3). 484–489. 66 indexed citations

Kroot, E. J. A., A. Weel, J. M. W. Hazes, et al.. (2005). Diagnostic value of blind synovial biopsy in clinical practice. Lara D. Veeken. 45(2). 192–195. 15 indexed citations

Tjioe, Milan, M. Gerritsen, Alfons A den Broeder, et al.. (2003). Adalimumab, a fully human anti‐TNF‐α monoclonal antibody, treatment does not influence experimental UV response in the skin of rheumatoid arthritis patients. Experimental Dermatology. 12(4). 460–465. 6 indexed citations

Kroot, E. J. A., et al.. (2001). Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. Arthritis & Rheumatism. 44(6). 1254–1260. 64 indexed citations

Kroot, E. J. A., et al.. (2001). Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study.. PubMed. 28(7). 1511–7. 40 indexed citations

Kroot, E. J. A., B.A.W. de Jong, M. A. van Leeuwen, et al.. (2000). The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis & Rheumatism. 43(8). 1831–1835. 509 indexed citations breakdown →

10.

Kroot, E. J. A., et al.. (2000). No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Annals of the Rheumatic Diseases. 59(12). 954–958. 108 indexed citations

11.

Kroot, E. J. A., Leo B. A. Van De Putte, & Piet L. C. M. van Riel. (1999). Management of therapy-resistant rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 13(4). 737–752. 6 indexed citations

12.

Vleuten, C.J.M. van der, E. J. A. Kroot, E.M.G.J. de Jong, & P.C.M. van de Kerkhof. (1996). The immunohistochemical effects of a single challenge with an intermediate dose of ultravilet B on normal human skin. Archives of Dermatological Research. 288(9). 510–516. 21 indexed citations

13.

Vleuten, C.J.M. van der, E. J. A. Kroot, E.M.G.J. de Jong, & P.C.M. van de Kerkhof. (1996). The immunohistochemical effects of a single challenge with an intermediate dose of ultraviolet B on normal human skin. Archives of Dermatological Research. 288(9). 510–516. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact